{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:08:05Z","timestamp":1773659285692,"version":"3.50.1"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81170307"],"award-info":[{"award-number":["81170307"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013286","name":"Specialized Research Fund for the Doctoral Program of Higher Education of China","doi-asserted-by":"publisher","award":["20120141110013"],"award-info":[{"award-number":["20120141110013"]}],"id":[{"id":"10.13039\/501100013286","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.ijcard.2016.03.028","type":"journal-article","created":{"date-parts":[[2016,3,15]],"date-time":"2016-03-15T22:47:56Z","timestamp":1458082076000},"page":"57-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Carabin: Endogenous calcineurin inhibitor, a potential diagnostic and therapeutic target for cardiac hypertrophy in heart failure"],"prefix":"10.1016","volume":"212","author":[{"given":"Xin","family":"Yi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuejun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2016.03.028_bb0005","doi-asserted-by":"crossref","DOI":"10.1038\/nrcardio.2015.137","article-title":"New medical therapies for heart failure","author":"von Lueder","year":"2015","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ijcard.2016.03.028_bb0010","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s00059-015-4215-5","article-title":"Epidemiology and prognosis of heart failure","volume":"40","author":"Edelmann","year":"2015","journal-title":"Herz"},{"key":"10.1016\/j.ijcard.2016.03.028_bb0015","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/FJC.0000000000000126","article-title":"Targeting cardiac hypertrophy: toward a causal heart failure therapy","volume":"64","author":"Bisping","year":"2014","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ijcard.2016.03.028_bb0020","doi-asserted-by":"crossref","first-page":"262","DOI":"10.2174\/157340311799960618","article-title":"Transcription factors in heart: promising therapeutic targets in cardiac hypertrophy","volume":"7","author":"Kohli","year":"2011","journal-title":"Curr. Cardiol. Rev."},{"key":"10.1016\/j.ijcard.2016.03.028_bb0025","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1073\/pnas.97.3.1196","article-title":"Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy","volume":"97","author":"Taigen","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijcard.2016.03.028_bb0030","doi-asserted-by":"crossref","first-page":"H856","DOI":"10.1152\/ajpheart.00353.2013","article-title":"NFAT transcription factor regulation by urocortin II in cardiac myocytes and heart failure","volume":"306","author":"Walther","year":"2014","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ijcard.2016.03.028_bb0035","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nature05476","article-title":"Feedback inhibition of calcineurin and Ras by a dual inhibitory protein Carabin","volume":"445","author":"Pan","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ijcard.2016.03.028_bb0040","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1161\/CIRCULATIONAHA.114.010686","article-title":"Carabin protects against cardiac hypertrophy by blocking calcineurin, Ras, and Ca2+\/calmodulin-dependent protein kinase II signaling","volume":"131","author":"Bisserier","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.03.028_bb0045","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1073\/pnas.031371998","article-title":"Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo","volume":"98","author":"De Windt","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijcard.2016.03.028_bb0050","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.cardiores.2004.04.002","article-title":"Interference of antihypertrophic molecules and signaling pathways with the Ca2+-calcineurin-NFAT cascade in cardiac myocytes","volume":"63","author":"Fiedler","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ijcard.2016.03.028_bb0055","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1161\/CIRCRESAHA.107.165985","article-title":"PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT signaling","volume":"102","author":"Jeong","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2016.03.028_bb0060","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/cvr\/cvv205","article-title":"Gene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translation","volume":"108","author":"Rincon","year":"2015","journal-title":"Cardiovasc. Res."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316304399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316304399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:37:11Z","timestamp":1759091831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527316304399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":12,"alternative-id":["S0167527316304399"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.03.028","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carabin: Endogenous calcineurin inhibitor, a potential diagnostic and therapeutic target for cardiac hypertrophy in heart failure","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.03.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}